Jaguar Health, Inc.
(NASDAQ:JAGX)
$0.59
0.02 (4.30%)
At Close: 4:00 PM
$0.60
0.00 (0.59%)
After Market: 3:43 AM
JAGX Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
JAGX Stock Price Today
Jaguar Health, Inc. (JAGX) stock rallied over 4.30% intraday to trade at $0.5945 a share on NASDAQ. The stock opened with a gain of 3.51% at $0.59 and touched an intraday high of $0.60, rising 4.30% against the last close of $0.57. The Jaguar Health, Inc. in stock market went to a low of $0.58 during the session.
JAGX Stock Snapshot
$0.57
Prev. Close
9.09 Million
Market Cap
$0.58
Day Low
$0.59
Open
1.98 Million
Number of Shares
$0.60
Day High
N/A
P/E ratio
-39.61
EPS (TTM)
0.75
Cash Flow per Share
73.00
Free Float in %
0.52
Book Value
437926.00
Volume
JAGX Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2023-02-14 | $3.42 | $3.47 | $3.18 | $3.23 | 412499.00 |
| 2023-02-13 | $4.03 | $4.08 | $3.41 | $3.45 | 429800.00 |
| 2023-02-10 | $4.22 | $4.22 | $3.99 | $4.03 | 198500.00 |
| 2023-02-08 | $4.46 | $4.52 | $4.17 | $4.19 | 302701.00 |
| 2023-02-07 | $4.50 | $4.56 | $4.37 | $4.49 | 296500.00 |
| 2023-02-06 | $4.82 | $4.87 | $4.50 | $4.53 | 338900.00 |
| 2023-02-03 | $4.56 | $5.04 | $4.48 | $4.70 | 974116.00 |
| 2023-02-02 | $4.56 | $4.60 | $4.44 | $4.52 | 254100.00 |
| 2023-02-01 | $4.71 | $4.79 | $4.49 | $4.54 | 337700.00 |
| 2023-01-31 | $4.65 | $4.68 | $4.46 | $4.53 | 168700.00 |
Contact Details
Company Information
Employees60.00
Beta1.73
Sales or Revenue$11.3 Million
5Y Sales Change22.30%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
Frequently Asked Questions
What is the current Jaguar Health, Inc. (JAGX) stock price?
Jaguar Health, Inc. (NASDAQ: JAGX) stock price is $0.59 in the last trading session. During the trading session, JAGX stock reached the peak price of $0.60 while $0.58 was the lowest point it dropped to. The percentage change in JAGX stock occurred in the recent session was 4.30% while the dollar amount for the price change in JAGX stock was $0.02.
JAGX's industry and sector of operation?
The NASDAQ listed JAGX is part of Biotechnology industry that operates in the broader Healthcare sector. Jaguar Health, Inc. , a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea.
Who are the executives of JAGX?
Dr. Karen J. Brunke Ph.D.
Executive Vice President of Corporation & Bus. Devel.
Mr. Peter Hodge
Senior Director of Investor Relations, Bus. Devel. & Special Events
Dr. Michael K. Guy D.V.M., M.S., Ph.D.
Vice President of Preclinical & Nonclinical Studies
Ms. Lisa A. Conte
Founder, Chief Executive Officer, Pres & Director
How JAGX did perform over past 52-week?
JAGX's closing price is 0.16% higher than its 52-week low of $0.46 where as its distance from 52-week high of $28.5 is -0.99%.
How many employees does JAGX have?
Number of JAGX employees currently stands at 60.00. JAGX operates from 200 Pine Street</br>San Francisco, CA 94104</br>US.
Link for JAGX official website?
Official Website of JAGX is: https://jaguar.health
How do I contact JAGX?
JAGX could be contacted at phone #415 371 8300 and can also be accessed through its website. JAGX operates from 200 Pine Street</br>San Francisco, CA 94104</br>US.
How many shares of JAGX are traded daily?
JAGX stock volume for the day was 437926.00 shares. The average number of JAGX shares traded daily for last 3 months was 3.67 Million.
What is the market cap of JAGX currently?
The market value of JAGX currently stands at $9.09 Million with its latest stock price at $0.59 and 1.98 Million of its shares outstanding.